Company intelligence / Profile preview
Guangdong Life Strong Pharmaceutical
- Ownership
- Private
- Development stage
- Other
Overview
Guangdong Life Strong Pharmaceutical develops and commercializes a range of traditional Chinese medicines and generic drugs, including exclusive formulations for diabetes (e.g., Shensi Jiangtang Tablets) that are included in the National Medical Insurance and Essential Drug Lists, with substantial market coverage and ongoing participation in national bulk procurement programs.
- Therapeutic areas
- EndocrinologyInfectious DiseasesGastroenterologyPulmonologyOther
- Modalities
- Small moleculeHerbal medicineTraditional Chinese medicine
- Industry
- Biotech
Drug pipeline
4 assets3 more assets in the full pipeline.
Request access →Beyond the preview
Go deeper on Guangdong Life Strong Pharmaceutical.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Licensing & deals
Full profile accessExplore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Full profile accessTrace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Full profile accessCompare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Full profile accessExplore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Full profile accessConnect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Guangdong Life Strong Pharmaceutical.